News

James Ellison, M.D., M.P.H., and IBX’s Rodrigo Cerdá, M.D., M.P.H., back Jefferson Health primary care screening to catch dementia care needs early and coordinate support.

During the first part of a wide-ranging interview with MHE, Hunter discussed behavioral health and financial pressures on the Medicaid managed care plna he runs in Oregon.

The FDA has approved Sotyktu (deucravacitinib) as the first selective TYK2 inhibitor for adults with active psoriatic arthritis.

The state of Utah, which has a policy of encouraging AI, is allowing Doctronic, an artificial intelligence startup, to provide AI-powered automated prescription renewals. Critics express concern about "autonomous medical practice."

Phase 4 acute pain study shows Journavx helps more than 90% of plastic surgery patients achieve opioid-free recovery with strong ratings and mild side effects.

A study published in Substance Use and Addiction found that combining nicotine replacement therapy with a rewards-based contingency management program helped people with HIV achieve higher short-term smoking cessation rates than nicotine replacement therapy alone.

Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and programs at health systems.

Jaewon Ryu, M.D., J.D., CEO of Risant Health, discusses the role of accountable care organizations in supporting value-based practices at health systems.

The researchers who conducted the study caution that the largest effect they identified was seen in tumors where progression may be inherently slow.

Vakharia was in the inaugural class of our Emerging Leaders in Healthcare recognition program in 2017. We circled back to find out what he is up to.

A generic fluticasone from Glenmark Specialty will be available this month, but there is no information yet on pricing.

Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 other states consider similar cuts amid rising program costs and stagnant federal funding.

Putting money directly in the hands of individuals to buy health insurance would unleash consumer forces, say supporters. Others see the plan as undercutting insurance markets and a “consumerism fantasy" with crucial details lacking.

Lindsay Greenleaf, J.D., MBA, and Nicolas Ferreyros offered insight and analysis during a March 3 webinar about healthcare policy and politics.

A recent American Cancer Society study found that colorectal cancer is increasingly common, especially in adults under 50. Test your current knowledge with this slideshow and learn what you can be doing to prevent it.

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.

As World Obesity Day spotlights rising obesity rates, GLP-1s reshape treatment and coverage debates, with persistence, affordability and long-term value driving payer decisions.

A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of lower surgery rates.

UT Southwestern researchers found that testosterone may increase susceptibility to staph infections by activating bacterial communication pathways.

The combination of acetaminophen and morphine provides slightly better early pain relief than morphine alone in emergency departments, particularly for patients with nontraumatic, nerve-related pain.

David Cordani is retiring after 17 years in the CEO role. he will join the board of directors as executive chair.

The first patient was enrolled in a trial of the inhaled insulin product for older children and adolescents who have been recently diagnosed with Type 1 diabetes.

Zahra Mahmoudjafari explains how cell and gene therapy programs succeed with strong infrastructure, pharmacy leadership, payer alignment, and workflows protecting safety and finances.

Tests for the DNA of the HPV virus might replace other ways of monitoring for recurrence in patients with cervical cancer.

The researchers caution, though, that causality cannot be inferred from the association found in an observational study.

A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma skin cancers.